216 related articles for article (PubMed ID: 11759540)
1. ["Academic detailing"].
Chabot JM
Rev Prat; 2001 Oct; 51(15):1687-8. PubMed ID: 11759540
[No Abstract] [Full Text] [Related]
2. Prescribing practices.
Lexchin J
CMAJ; 1994 Jul; 151(2):140. PubMed ID: 8039058
[No Abstract] [Full Text] [Related]
3. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
4. A gap in the market.
Lancet Neurol; 2005 Sep; 4(9):517. PubMed ID: 16109355
[No Abstract] [Full Text] [Related]
5. Educating ourselves.
Potdar RD
Indian Pediatr; 2000 Nov; 37(11):1287-8. PubMed ID: 11086325
[No Abstract] [Full Text] [Related]
6. Academic detailing.
Nemec PB
Psychiatr Rehabil J; 2011; 34(3):257-9. PubMed ID: 21208867
[No Abstract] [Full Text] [Related]
7. Academic drug detailing: an evidence-based alternative.
Kondro W
CMAJ; 2007 Feb; 176(4):429-31. PubMed ID: 17296946
[No Abstract] [Full Text] [Related]
8. Medicine that's a little too personalized.
Gilbert S
Hastings Cent Rep; 2011; 41(4):Inside back cover. PubMed ID: 21845924
[No Abstract] [Full Text] [Related]
9. A philosophy for marketing independent practice.
Koetting RA
J Am Optom Assoc; 1988 Jan; 59(1):58-61. PubMed ID: 3343484
[No Abstract] [Full Text] [Related]
10. Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing.
Groves KE; Schellinck T; Sketris I; MacKinnon NJ
Res Social Adm Pharm; 2010 Sep; 6(3):257-67. PubMed ID: 20813338
[TBL] [Abstract][Full Text] [Related]
11. Stretching the managed care dollar in the new millennium: the practice of detailing primary care physicians.
Hill CD; Bunn DN; Hawkins JR
Manag Care Q; 2002; 10(2):18-23. PubMed ID: 12148477
[TBL] [Abstract][Full Text] [Related]
12. Learning how drug companies promote medicines in Nepal.
Giri BR; Shankar PR
PLoS Med; 2005 Aug; 2(8):e256. PubMed ID: 16120011
[TBL] [Abstract][Full Text] [Related]
13. Why aren't we using beta blockers after acute MI?
Weichel AS
Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
[No Abstract] [Full Text] [Related]
14. The role of industry in brand or generic drug recognition.
Stephens MB; Maslach A; Childress M
Fam Med; 2009 Feb; 41(2):82-3. PubMed ID: 19184678
[No Abstract] [Full Text] [Related]
15. Drug advertisements: what a physician should know.
Ghosh RK; Ghosh SM
N Z Med J; 2010 May; 123(1314):154-6. PubMed ID: 20581923
[No Abstract] [Full Text] [Related]
16. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.
Bradford WD; Kleit AN; Nietert PJ; Steyer T; McIlwain T; Ornstein S
Health Aff (Millwood); 2006; 25(5):1371-7. PubMed ID: 16966735
[TBL] [Abstract][Full Text] [Related]
17. Consequences of direct-to-consumer advertising of prescription drugs.
Lexchin J
Can Fam Physician; 1997 Apr; 43():594-6, 602-5. PubMed ID: 9111973
[No Abstract] [Full Text] [Related]
18. A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy.
Naughton C; Feely J; Bennett K
Fam Pract; 2007 Oct; 24(5):475-80. PubMed ID: 17670803
[TBL] [Abstract][Full Text] [Related]
19. 'A pill for every ill': explaining the expansion in medicine use.
Busfield J
Soc Sci Med; 2010 Mar; 70(6):934-41. PubMed ID: 20096496
[TBL] [Abstract][Full Text] [Related]
20. Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.
Graham SD; Hartzema AG; Sketris IS; Winterstein AG
Ann Pharmacother; 2008 Jun; 42(6):749-56. PubMed ID: 18430793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
